Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02051686 · ClinicalTrials.gov registry record · NA
Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid
A NA study of Acetabulum Fractures, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT02051686 is a NA study of Acetabulum Fractures that has completed, run by University of Missouri-Columbia. The registered enrollment target is 88 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02051686, a NA study of Acetabulum Fractures, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is investigating the use of tranexamic acid (TXA) in patients with pelvis and/or hip socket fractures that require surgery. TXA is FDA-approved in patients with hemophilia for short-term use to reduce hemorrhage and the need for replacement blood during tooth extraction. However, it has also been used extensively in severely injured patients after major trauma and during elective hip and knee replacements. Previous studies indicate TXA may reduce blood loss and the need for blood transfusions while being safe for use in most patients. TXA is fairly inexpensive and easy to obtain. The purpose of this study is to determine if TXA will make surgery in patients with pelvis and/or hip socket fractures safer and more cost efficient.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tranexamic Acid
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02051686
The ClinicalTrials.gov registry entry for NCT02051686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acetabulum Fractures appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02051686 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02051686 about?
NCT02051686 is a clinical study titled "Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid". This study is investigating the use of tranexamic acid (TXA) in patients with pelvis and/or hip socket fractures that require surgery. TXA is FDA-approved in patients with hemophilia for short-term use to reduce hemorrhage and the need for replacement blood during tooth extraction. However, it has a...
What is the current status of trial NCT02051686?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2013-06. Estimated completion is 2016-12.
What conditions does trial NCT02051686 study?
This clinical trial studies the following conditions: Acetabulum Fractures.
What interventions are being tested in trial NCT02051686?
The interventions under investigation include: Placebo (DRUG), Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT02051686?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02051686 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.